Submission of Monitoring Agency Report for the quarter ended on 31st March, 2026
PINELABS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
CARE Ratings has submitted its monitoring agency report for Pine Labs' Rs. 2,080 crore IPO (November 2025). As of Q4FY26 (March 31, 2026), Rs. 797.28 crore (38.3%) has been utilized out of the IPO proceeds. The company has fully repaid Rs. 532 crore of borrowings and invested Rs. 59.99 crore in overseas subsidiaries (Singapore, Malaysia, UAE). Technology and IT investments stand at Rs. 106.17 crore, with Rs. 1,282.72 crore remaining unutilized and parked in bank fixed deposits. A minor accounting correction was noted: Rs. 12.96 crore GST was inadvertently omitted in Q3 reporting and has been corrected. No material deviations from stated IPO objects were found, and no implementation delays were reported.
The report is largely positive for shareholders - IPO funds are being deployed as promised with full repayment of debt completed. The small GST correction (0.6% of IPO) is administrative in nature and poses no concern. The large unutilized balance (Rs. 1,282 crore) earns 5.85-6.40% in FDs, indicating prudent fund management while the company executes its technology and expansion plans.